Stanford Root

Schedule

Stanford Root

Schedule

MED 225

Introduction to Drug Development: A Guide to Therapeutic Innovation

UNITS:1
GRADING:Medical Satisfactory/No Credit
LEVEL:Graduate
GER:—

This course is designed for medical students, trainees, basic scientists, clinicians and clinician-scientists at Stanford to provide an educational and practical perspective on the essential issues in drug development. Using a blend of seminars and dynamic workshops, the curriculum is focused on educating the audience on all stages of drug development and related research and business processes - from discovery and translational science and how to launch new projects to analyzing data, communication and interpretation of results of clinical trials, regulatory issues and commercial considerations in product development. The emphasis will be on cardiovascular applications. Proposed seminar topics are attached and include How Drugs Are Discovered and Developed, Case Studies of the various challenges in Drug Development, Cardiac Safety, Moving a Compound through the Drug Development Process, and the FDA Advisory Committee Process. http://med.stanford.edu/cvi/education/cvi-courses/med225.html

Syllabus not available for this section

Sections

0 Terms
No sections available.

MED 225: Introduction to Drug Development: A Guide to Therapeutic Innovation

1 units · Medical Satisfactory/No Credit

This course is designed for medical students, trainees, basic scientists, clinicians and clinician-scientists at Stanford to provide an educational and practical perspective on the essential issues in drug development. Using a blend of seminars and dynamic workshops, the curriculum is focused on educating the audience on all stages of drug development and related research and business processes - from discovery and translational science and how to launch new projects to analyzing data, communication and interpretation of results of clinical trials, regulatory issues and commercial considerations in product development. The emphasis will be on cardiovascular applications. Proposed seminar topics are attached and include How Drugs Are Discovered and Developed, Case Studies of the various challenges in Drug Development, Cardiac Safety, Moving a Compound through the Drug Development Process, and the FDA Advisory Committee Process. http://med.stanford.edu/cvi/education/cvi-courses/med225.html

More MED courses

  • MED 216: Generative AI and Medicine (BMDS 281)
  • MED 219: Intro to Housing Equity, Homeless Health, Harm Reduction, and Community-led Case Management
  • MED 220: Bioethical Challenges of New Technology
  • MED 222: You Can Make a Difference in Primary Care (MED 155)
  • MED 223: Cardiovascular and Pulmonary Sciences Seminar
  • MED 224: Social Entrepreneurship and Innovation Lab (SE Lab) - Human & Planetary Health (HRP 224, PUBLPOL 224)
  • MED 226: Practical Approaches to Global Health Research (EPI 237, INTLPOL 290)
  • MED 227: Drug Development: Key Issues in Regulation, Benefit vs. Risk, and Commercialization
  • MED 229: Longevity (HUMBIO 149L, PSYCH 102)
  • MED 231: Healthcare and Firearms
  • MED 232: Global Health: Scaling Health Technology Innovations in Low Resource Settings
  • MED 233: Global Health: Beyond Diseases and International Organizations

All MED courses · All departments